MLLT3 and acute myeloid leukemia: We used a syngeneic HOXA9–MEIS1 retroviral overexpression transplant model that recapitulates much of MLL-AF9 AML biology while retaining applicability to non-MLL-rearranged AML types with prominent HOXA9 and MEIS1 activity24.